CUX1

cut like homeobox 1, the group of CUT class homeoboxes and pseudogenes|Golgins

Basic information

Region (hg38): 7:101815904-102283958

Previous symbols: [ "CUTL1" ]

Links

ENSG00000257923NCBI:1523OMIM:116896HGNC:2557Uniprot:P39880, Q13948AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • global developmental delay with or without impaired intellectual development (Moderate), mode of inheritance: AD
  • global developmental delay with or without impaired intellectual development (Strong), mode of inheritance: AD
  • autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Global developmental delay with or without impaired intellectual developmentADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic30014507

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CUX1 gene.

  • Global developmental delay with or without impaired intellectual development (7 variants)
  • Neurodevelopmental disorder (1 variants)
  • Inborn genetic diseases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUX1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
39
clinvar
10
clinvar
49
missense
1
clinvar
153
clinvar
29
clinvar
4
clinvar
187
nonsense
7
clinvar
7
clinvar
5
clinvar
19
start loss
0
frameshift
1
clinvar
11
clinvar
7
clinvar
19
inframe indel
6
clinvar
1
clinvar
1
clinvar
8
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
1
clinvar
1
clinvar
7
splice region
5
4
4
13
non coding
1
clinvar
7
clinvar
8
Total 9 23 172 71 22

Variants in CUX1

This is a list of pathogenic ClinVar variants found in the CUX1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-101816042-T-C Likely benign (Jun 13, 2018)752193
7-101816046-G-A CUX1-related disorder Uncertain significance (Sep 26, 2024)3344186
7-101816068-A-G Inborn genetic diseases Uncertain significance (May 03, 2021)2361302
7-101816091-C-T Global developmental delay with or without impaired intellectual development Likely pathogenic (Aug 31, 2018)618995
7-101816094-G-A Intellectual disability • Global developmental delay with or without impaired intellectual development Conflicting classifications of pathogenicity (Aug 03, 2020)977603
7-101816096-C-T Inborn genetic diseases Uncertain significance (Feb 12, 2021)2228985
7-101817663-G-T Uncertain significance (Jan 01, 2024)3367276
7-101916137-C-T Uncertain significance (Jul 06, 2022)1695434
7-101916181-C-T not specified Uncertain significance (Jul 29, 2022)1704521
7-101916207-C-G Uncertain significance (Jan 29, 2024)3368540
7-101916213-G-C Inborn genetic diseases Uncertain significance (Jun 01, 2023)2555097
7-101916233-G-A CUX1-related disorder Benign (Dec 04, 2019)3060457
7-102028117-C-G Inborn genetic diseases Uncertain significance (Oct 26, 2022)3079037
7-102028118-G-A Likely benign (Aug 01, 2024)3341709
7-102070310-T-C Global developmental delay with or without impaired intellectual development Benign (Jul 30, 2021)1255424
7-102070337-A-G Global developmental delay with or without impaired intellectual development Pathogenic (Dec 19, 2022)1803930
7-102070339-A-G Uncertain significance (May 26, 2023)3343750
7-102070411-G-A CUX1-related disorder Benign/Likely benign (Aug 01, 2024)709065
7-102070418-G-A Inborn genetic diseases Likely pathogenic (Jan 19, 2022)985488
7-102097326-T-G Global developmental delay with or without impaired intellectual development Benign (Jul 30, 2021)1255425
7-102097330-C-A Global developmental delay with or without impaired intellectual development Benign (Jul 30, 2021)1255426
7-102097362-A-C Inborn genetic diseases Uncertain significance (Apr 04, 2024)3270349
7-102097370-T-C Global developmental delay with or without impaired intellectual development Uncertain significance (Feb 06, 2020)1027902
7-102097378-T-A Uncertain significance (Jan 08, 2024)3367592
7-102097381-G-C Global developmental delay with or without impaired intellectual development Uncertain significance (Sep 22, 2024)3362727

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CUX1protein_codingprotein_codingENST00000360264 24468291
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.005.47e-81257370111257480.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.755438510.6380.00005729753
Missense in Polyphen420.0070.19993283
Synonymous-0.5413963831.040.00002853009
Loss of Function7.25672.70.08250.00000367824

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009050.0000904
Ashkenazi Jewish0.0001030.0000992
East Asian0.0001630.000109
Finnish0.00004720.0000462
European (Non-Finnish)0.00004430.0000439
Middle Eastern0.0001630.000109
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be involved in intra-Golgi retrograde transport. {ECO:0000269|PubMed:15718469}.;
Pathway
Disease;Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi traffic;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.449

Intolerance Scores

loftool
0.407
rvis_EVS
-1.87
rvis_percentile_EVS
2.01

Haploinsufficiency Scores

pHI
0.784
hipred
Y
hipred_score
0.792
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.783

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cux1
Phenotype
skeleton phenotype; renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;retrograde transport, vesicle recycling within Golgi;regulation of transcription by RNA polymerase II;multicellular organism development;peptidyl-tyrosine phosphorylation;Golgi vesicle transport;positive regulation of dendrite morphogenesis
Cellular component
Golgi membrane;nucleus;nucleoplasm;Golgi apparatus;cytosol
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;protein tyrosine kinase activity;protein binding, bridging;sequence-specific DNA binding